• About
  • Vision
  • Origins
  • Team
  • Science
  • Rewriting RNA
  • Ascidian's Approach
  • Publications & Presentations
  • Pipeline
  • Programs
  • News
  • Press Releases
  • In the News
  • Careers
  • Ascidian Life
  • Opportunities

Get in Touch

LinkedIn Twitter

Science
Publications & Presentations

  • Rewriting RNA
  • Ascidian's Approach
  • Publications & Presentations

January 10, 2023 | Corporate Presentation

Ascidian Therapeutics: Rewriting RNA

Presented at the 41st Annual J.P. Morgan Healthcare Conference

By Romesh Subramanian, PhD

October 11, 2022 | Scientific Poster

ABCA4 pre-mRNA exon editing in vitro and in vivo (ESGCT)

Presented at the European Society of Gene & Cell Therapy – 29th Congress

By Akiko Doi, PhD, et al.

July 10, 2022 | Scientific Poster

ABCA4 pre-mRNA exon editing in vitro and in vivo (GRC)

Presented at the 2022 Gordon Research Conference on Post-Transcriptional Gene Regulation

By Jesse M. Gray, PhD, et al.

May 19, 2022 | Presentation

Optimization of pre-mRNA exon editing for efficient rescue of protein expression

Presented at the American Society for Gene and Cell Therapy – 25th Annual Meeting

By Kirk Burkhart, PhD, et al.

May 19, 2022 | Presentation

A large-scale exon editing solution for treating genetic and complex disorders

A large-scale exon editing solution for treating genetic and complex disorders

By Robert D. Bell, PhD, et al.

May 16, 2022 | Scientific Poster

Evaluation of ABCA4 RNA exon editing and replacement in non-human primate

Presented at the American Society of Gene and Cell Therapy – 25th Annual Meeting

By Rebekka Krumbach, PhD, et al.

COPYRIGHT © ASCIDIAN THERAPEUTICS, INC. | ALL RIGHTS RESERVED.

Terms of Use Privacy Policy
LinkedIn Twitter

outreach@ascidian-tx.com ASCIDIAN THERAPEUTICS
80 GUEST STREET
FOURTH FLOOR
BOSTON MA 02135

ATP IS DEVELOPING THE NEXT GENERATION OF TRANSFORMATIVE LIFE SCIENCES COMPANIES.

Back to top